Altimmune, Inc. — Director's Dealing 2023

Sep 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2023-09-28

Reporting Person: Pisano Wayne (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-28	Stock Options (option to buy)	$2.50	A	26100	Acquired	2033-09-28	Common Stock, par value $0.0001 (26100)	Direct

Footnotes

F1: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date.